) shares tick up in pre-market trading — continuing into the green after the market open — after the pharmaceutical giant raised its full-year profit outlook and topped first-quarter earnings estimates on the top and bottom lines.Pressure building on Bank of Canada: What economists say about slowing GDPEnbridge stock has barely moved in the last few years, with ongoing issues. But there are still reasons that could make it work for investors.
-- Toronto-Dominion Bank has taken an initial provision of $450 million in connection with US investigations into its anti-money laundering practices, and said it expects additional penalties to come.
-- The cocoa market was whipsawed by extreme volatility in the futures market on Tuesday amid a lack of liquidity.
Profit Outlook Pharmaceutical Giant Earnings Estimates Anjalee Khemlani Market Open Pre-Market Trading
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer, Thermo Fisher Among 200 Companies Warned by FTC Over DealsThe US Federal Trade Commission warned hundreds of companies including Pfizer Inc., Baxter International Inc. and Thermo Fisher Scientific Inc. that it could challenge their acquisitions even after the deadline for the agency’s antitrust review had passed.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Pfizer to Seek Wider Use of RSV Shot After Trial in Young AdultsPfizer Inc.’s RSV shot produced immune reactions in young adults at higher risk of severe illness just as well as in older people, spurring the company’s plans to apply for wider US approval.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Pfizer RSV shot meets goals in trial of high-risk adults under age 60Explore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »
Pfizer unveils positive phase 3 trial results for RSV VaccinePfizer (PFE) has released the results from its Phase 3 clinical trial for its RSV vaccine. The trial showed positive outcomes for adults aged 18-59, widening...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Pfizer’s First Gene Therapy Gets Approval for Clotting DisorderPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
“WHERE ARE YOUR ETHICS?”: Lady Gaga Slammed For Promoting Migraine Med'It's like you've become a complete[ly] different person,' outraged fans said as they criticized Lady Gaga for the commercial for Pfizer's migraine medication.
Source: boredpanda - 🏆 18. / 72 Read more »